IP Library Granted Patent US 10,973,409
Granted Patent B2
US 10,973,409 · App. 16/109,485 · Granted Apr 13, 2021

Objective testing of vergence dysfunction for using dynamic vergence testing platform including 3D head mounted display system with integrated eye tracking technology

Inventors: Alexander D. Kiderman (Pittsburgh, PA); Robin C. Ashmore (Pittsburgh, PA)
Assignee: NEURO KINETICS
A61B3/113A61B3/0041G02B27/0093G02B27/017
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,973,409
App. No.
16/109,485
Granted
Apr 13, 2021
Kind
B2
Abstract

An objective testing of vergence dysfunction comprising the steps of: providing a head mounted goggle based stimulus generating eye tracking unit to the subject; presenting visual stimulus to the subject, wherein the visual stimulus is in the head mounted goggle based system and forms the optical target stimulus for at least one vergence test; obtaining objective physiologic response of the subject from the head mounted goggle unit based upon each of the visual stimulus presented to the subject in each test; and using the objective physiologic responses to diagnose the presence of vergence dysfunction. On objective portable head mounted goggle based stimulus generating eye tracking unit for vergence testing is discloses as is a method of method of vergence recovery convalescence.

Claims (30)

1. An objective testing of vergence dysfunction comprising the steps of:

providing a head mounted goggle based stimulus generating eye tracking unit to the subject;

presenting visual stimulus to the subject, wherein the visual stimulus is in the head mounted goggle based system and forms the optical target stimulus for at least one vergence test, wherein at least one vergence test comprises a saccade vergence test that includes presenting targets at different virtual depths in a punctuated fashion whereby sudden shifts in target position are presented to the subject followed by delays where the targets are stationary;

obtaining objective physiologic response of the subject from the head mounted goggle unit based upon each of the visual stimulus presented to the subject in each test; and

using the objective physiologic responses to diagnose the presence of vergence dysfunction.

2. The objective testing of vergence dysfunction according to claim 1 wherein the optical target stimulus is presented in the context of background stimuli configured to appear as 3 dimensional objects that surround and orientate the target stimulus in virtual 3 dimensional space.

3. The objective testing of vergence dysfunction according to claim 2 wherein the background stimuli is in the form of a box tunnel.

4. The objective testing of vergence dysfunction according to claim 1 wherein the objective physiologic responses used to diagnose the presence of vergence dysfunction includes Left and right eye response time to saccade vergence tests.

5. The objective testing of vergence dysfunction according to claim 1 wherein the objective physiologic responses used to diagnose the presence of vergence dysfunction includes Symmetry of left and right eye movement of saccade vergence tests.

6. The objective testing of vergence dysfunction according to claim 1 wherein the objective physiologic responses used to diagnose the presence of vergence dysfunction includes at least one of i) Left and right eye response time to saccade vergence tests, ii) Symmetry of left and right eye movement of saccade vergence tests, iii) Amplitude of-Eye movement of saccade vergence tests, and iv) % of saccade of saccade vergence tests.

7. An objective testing of vergence dysfunction comprising the steps of:

providing a head mounted goggle based stimulus generating eye tracking unit to the subject;

presenting visual stimulus to the subject, wherein the visual stimulus is in the head mounted goggle based system and forms the optical target stimulus for at least one vergence test, wherein at least one vergence test comprises a smooth pursuit vergence test that includes presenting a continuously, smoothly transitioning movement of the stimuli configured to create the appearance of a target gradually moving toward or away from the subject in the virtual depth space;

obtaining objective physiologic response of the subject from the head mounted goggle unit based upon each of the visual stimulus presented to the subject in each test; and

using the objective physiologic responses to diagnose the presence of vergence dysfunction.

8. The objective testing of vergence dysfunction according to claim 7 wherein the smooth pursuit vergence test comprises having subjects visualized the stimulus moving towards and away in a sinusoidal pattern at about 0.1 Hz.

9. The objective testing of vergence dysfunction according to claim 7 wherein the objective physiologic responses used to diagnose the presence of vergence dysfunction includes at least one of i) measures of the angle of the left and right eye with the target at the nearest point and the farthest points in its sinusoidal movement in the smooth pursuit vergence testing, ii) a measure an amplitude of eye movement in the smooth pursuit vergence testing, iii) Lag time which is a measure of the delay between target movement and tracking eye movement in the smooth pursuit vergence testing, and iv) Symmetry which is a measure of the comparison of the left and the right eye movements in the smooth pursuit vergence testing.

10. An objective testing of vergence dysfunction comprising the steps of:

providing a head mounted goggle based stimulus generating eye tracking unit to the subject;

presenting visual stimulus to the subject, wherein the visual stimulus is in the head mounted goggle based system and forms the optical target stimulus for at least one vergence test, wherein at least one vergence test comprises an offset vergence test wherein the optical target stimulus is presented in a line offset from the midline between the subject's eyes;

obtaining objective physiologic response of the subject from the head mounted goggle unit based upon each of the visual stimulus presented to the subject in each test; and

using the objective physiologic responses to diagnose the presence of vergence dysfunction.

11. The objective testing of vergence dysfunction according to claim 10 wherein at least offset vergence test includes aligning the target with one of the subject's eyes.

12. The objective testing of vergence dysfunction according to claim 10 wherein using the objective physiologic responses to diagnose the presence of vergence dysfunction is used to diagnose mTBI.

13. The objective testing of vergence dysfunction according to claim 1 wherein using the objective physiologic responses to diagnose the presence of vergence dysfunction is used to diagnose mTBI.

14. The objective testing of vergence dysfunction according to claim 7 wherein using the objective physiologic responses to diagnose the presence of vergence dysfunction is used to diagnose mTBI.

15. The objective testing of vergence dysfunction according to claim 7 wherein the optical target stimulus is presented in the context of background stimuli configured to appear as 3 dimensional objects that surround and orientate the target stimulus in virtual 3 dimensional space.

16. The objective testing of vergence dysfunction according to claim 15 wherein the background stimuli is in the form of a box tunnel.

17. The objective testing of vergence dysfunction according to claim 10 wherein the optical target stimulus is presented in the context of background stimuli configured to appear as 3 dimensional objects that surround and orientate the target stimulus in virtual 3 dimensional space.

18. The objective testing of vergence dysfunction according to claim 10 wherein the background stimuli is in the form of a box tunnel.

Assignments (7)
SECURITY INTEREST Recorded Jul 10, 2026
From: SPRYSON, INC.
To: DOVALIS SOLIS, CLAUDIA
Reel/Frame 075236/0943 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 17, 2024
From: NEURO KINETICS, INC.
To: SPRYSON INC.
Reel/Frame 066803/0430 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 14, 2024
From: NEURO KINETICS, INC.
To: NEUROLIGN USA, LLC
Reel/Frame 066775/0256 →
CHANGE OF NAME Recorded Oct 7, 2022
From: NEURO KINETICS, INC.
To: 128 GAMMA LIQUIDATION, INC.
Reel/Frame 061627/0550 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 7, 2022
From: 128 GAMMA LIQUIDATION, INC.
To: 128 GAMMA LIQUIDATING TRUST
Reel/Frame 061349/0606 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2022
From: NEURO KINETICS, INC.
To: NEUROLIGN USA, LLC.
Reel/Frame 061325/0437 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 4, 2018
From: KIDERMAN, ALEXANDER D.; ASHMORE, ROBIN C.
To: NEURO KINETICS
Reel/Frame 047665/0115 →
Continuity (3)
Continuation In Part PCTUS2017018862 · Feb 22, 2017
Provisional Application 62298304 · Feb 22, 2016
Related Publication 20190082954A1 · Mar 21, 2019
Cited By (1)
US 12,678,039